predispose to acute cholecystitis, acute pancreatitis, and ascending cholangitis [6] . Despite this risk, prophylactic concomitant cholecsytectomy is not often performed due to its association with increased BRS complications and only a minority of patients developing symptomatic gallstone disease [7, 8] . Patients with prior BRS often require biliary intervention including endoscopic retrograde cholangio-pancreatography (ERCP) for choledocholithiasis, recurrent pancreatitis, pancreaticobiliary neoplasms, biliary obstruction, and biliary leak [9 -11] .
Roux-en-Y gastric bypass (RYGB) constitutes the vast majority of BRSs, accounting for approximately 60 %-70 % of all BRSs [12] . In patients with prior RYGB BRS that require biliary intervention, alteration of the normal foregut anatomy may make access to the native biliary tree very challenging. Conventional ERCP has a success rate of approximately 50 % in patients with prior Whipple resection, with significant higher success rates (84 %) when used for biliary indications [13] . Transgastric access with laparoscopic methods along with endoscopic single and double balloon enteroscopy, have been described with varying methods of success [9, 14] . In patients with prior RYGB, a laparoscopic-assisted transgastric access with ERCP is recommended for assessment of the duodenum and biliary tree, and evaluation of chronic abdominal pain [15] .
To our knowledge, there are no large population-based studies comparing endoscopic (laparoscopic or enteroscopy-assisted ERCP) versus non-endoscopic (percutaneous cholangiography and surgical common bile duct exploration) procedures in patients with prior BRS that require biliary intervention. Thus, our aim was to estimate the prevalence of biliary interventions in patients with prior BRS and to evaluate clinical outcomes comparing endoscopic and non-endoscopic approaches. The clinical outcomes of interest were in-patient mortality, length of stay (LOS), and total hospital charges
Patients and methods

Data source
The Nationwide Inpatient Sample (NIS) Healthcare Cost Utilization Project (HCUP), an administrative claims databank, is the largest all-payer inpatient care database in the US [16] . The NIS is a compilation of more than 8 million inpatient admissions from approximately 1000 hospitals (representing about 85 % of all nonfederal hospitals). It is designed to approximate a 20 % stratified probability sample of patients from all nonfederal acute-care hospitals in the US. Discharge weights are provided, which allows extraction of national level estimates from the unweighted database information [16] .
The NIS-HCUP database was queried from 2007 to 2011 using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis and procedure for all adult patients (≥ 18 years) with a history of BRS undergoing biliary procedures (ERCP, percutaneous cholangiography (PTC) and surgical common bile duct exploration (CBDE). Due to the limited specificity of ICD-9-CM coding, we were unable to distinguish between laparoscopic, or enteroscopy-assisted ERCP. Therefore, these procedures were grouped into 1 category referred to as endoscopic biliary interventions. Primary endoscopic intervention is defined as the performanance of any endoscopic biliary intervention as the initial procedure for treatment. Primary non-endoscopic intervention is similarly defined as the performance of either PTC or CBDE as the initial therapeutic technique. Failed endoscopic intervention was defined as the performance of a non-endoscopic biliary intervention (PTC or CBDE) within 7 days after a primary endoscopic intervention. A history of prior BRS, etiologic factors for biliary intervention and associated diagnoses, and specific types of biliary intervention were queried by using specific ICD-9-CM codes (Appendix 1).
The Ohio State University Data and Specimen Policy and Human Subjects Research Policy does not require Institutional Review Board approval for population-based public data sets. Per 45 Code of Federal Regulations (CFR 46.101), research using certain publicly available data sets does not involve "human subjects."
Patients and outcomes
Patient-level variables included age, sex, race, median household income for patient's zip code (quartiles), and insurance status. Race/ethnicity was categorized as White, Black, Hispanic, and others. Insurance status was categorized as Medicare, Medicaid, private insurance, and uninsured/other based on the primary payer listed on the discharge record. Comorbidities for risk adjustment were derived from Agency for Healthcare Research and Quality (AHRQ) comorbidity measures based on the methods by Elixhauser [17] . Patients were given a score of < 3 or ≥ 3 based on the number of comorbidities. Hospital-related potential confounders were hospital location (urban vs. rural), hospital bed size (large, medium, small), and hospital teaching status (teaching vs. nonteaching). Hospital bed size was classified as small, medium, or large based on an algorithm developed by HCUP. Hospital region was classified by the US Census Bureau as Northeast, Midwest, South, or West.
Clinical outcomes of interest were inpatient mortality, LOS, and total hospital charges and we compared these in 2 groups of patients with prior BRS: (a) patients requiring primary endoscopic versus non-endoscopic biliary intervention, and (b) patients undergoing failed versus successful endoscopic biliary interventions. The LOS and total hospital charges were collectively referred to as healthcare resource utilization.
Statistical analysis
Categorical variables and continuous variables were tested for statistical significance with Chi-square tests and t tests, respectively. The mean and standard deviation were calculated for all continuous outcomes and frequency counts and percentages were calculated for all categorical outcomes. Temporal trends were assessed using the Cochrane-Armitage trend test. Univariate predictor variables with a P value < 0.1 were included in the multivariate analysis. Multivariate linear regression models were fit for continuous outcome variables and multivariate logistic regression models were fit for each dichotomous outcome. All results in the regression model were represented by an odds ratio (OR) and 95 % confidence interval (CI). All regression models were performed separately. Statistical significance was defined by P < 0.05. These analyses were performed on weighted data from the NIS database using SAS 9.3 (SAS Institute, Cary, NC) employing appropriate survey procedures to produce national estimates.
Missing data is enlisted in Appendix 2. Race was the variable with the most missing data (9.4 %) since certain states do not document race in discharge information. Other variables had less than 1 % missing data and these were dropped from the final analysis. Imputation was not performed as data was assumed to be missing at random.
Results
Trends in bariatric surgery, cholecystectomy, and biliary drainage procedures 
Patient characteristics and procedure indications
Endoscopic versus non-endoscopic biliary intervention
Demographics and hospital variables Univariate analysis (▶ Table 1 ) revealed that patients who underwent a primary endoscopic biliary intervention were younger, with fewer comorbid conditions, and were treated at teach- ing hospitals compared to those requiring primary non-endoscopic interventions. Gallstone-related disease was associated with more frequent primary endoscopic management while pancreaticobiliary neoplasms and bile duct injury were associated with primary non-endoscopic management.
Presence of associated emergent conditions
Acute pancreatitis (AP), as an associated diagnosis, was more frequent in patients requiring an endoscopic approach; however, sepsis, as an associated diagnosis, was more frequent in patients undergoing non-endoscopic biliary interventions (▶ Table 1 ). Multivariate analysis adjusting for demographics, hospital factors, and etiologies confirmed these findings. Sepsis was more than 2 times more likely to be associated with patients requiring non-endoscopic intervention (OR 2.13, 95 % CI 1.30, 3.50, P = 0.003). On the contrary, AP was more than 2 times more frequently associated with patients undergoing an endoscopic approach (OR = 2.44, 95 % CI 0.30, 0.56, P < 0.001).
Mortality and health care resource utilization
The overall in-hospital mortality rate for patients with prior BRS undergoing biliary intervention was 0.41 % (30 of 7,343 patients). Inpatient mortality was not significantly different between patients undergoing primary endoscopic versus primary non-endoscopic procedures (0.22 % vs. 0.69 %, P = 0.2) (▶ Table 1 ). However, non-endoscopic interventions were associated ▶ a) The cell's value is not displayed. As per data agreements with AHRQ, researchers cannot report any statistics where the number of observations in any given cell of analyzed data is ≤ 10. CBDE, common bile duct exploration; ERCP, endoscopy retrograde cholangiopancreatography; PTC, percutaneous transhepatic cholangiography with a longer length of hospital stay and greater total hospital charges. More specifically, patients with a primary non-endoscopic intervention stayed 1.77 (95 % CI 1.32, 2.21, P < 0.001) days longer and were charged $ 11,453 (95 % CI 5,811, 17,095, P < 0.001) more than those with a primary endoscopic intervention ( ▶ Table 2 ). Notably, patients who underwent any biliary intervention within 1 day of hospitalization accounted for significantly lower health care resource utilization (▶ Table 2 ).
Successful versus failed endoscopic interventions
Demographics and hospital variables A total of 4,482 patients with history of BRS underwent primary endoscopic interventions. Procedure success and failure rates were 88.3 % (n = 3,956) and 11.7 % (n = 526) respectively, P < 0.001. Univariate analysis (▶ Table 3 ) revealed that patients who had successful procedures were younger compared to ▶ those who had a failed procedure. Failed procedures were associated with more frequent cholecystectomies compared to successful procedures (47.1 % and 36.6 % respectively, P = 0.04).
Presence of associated emergent conditions
Acute pancreatitis was an associated diagnosis found more frequently in patients with successful endoscopic interventions while sepsis was an associated diagnosis more frequent in failed interventions (▶ Table 3 ). Specifically, sepsis was more than 2.7 times more likely to be associated with failed endoscopic interventions (OR 2.74, 95 % CI 1.15, 6.53, P = 0.02) compared to successful interventions.
Mortality and health care resource utilization
There was no documented death for patients with failed endoscopic interventions and all 10 deaths in the endoscopic intervention group occurred in patients with successful procedures. Failed endoscopic interventions accounted for greater healthcare resource utilization (longer LOS and greater total charges). Specifically, failed endoscopic interventions necessitated 2.17 (95 % CI 1.79, 3.33, P < 0.001) additional days of stay and $ 14,214 (95 % CI 3,749, 24,679, P = 0.008) more than successful interventions (▶ Table 4 ). Patients who underwent either successful or failed endoscopic intervention within 1 day of hospitalization accounted for significantly lower health care resource utilization, P < 0.001.
Discussion
In this population-based study analysis of all biliary interventions in hospitalized patients with prior BRS from 2007 to 2011, we have demonstrated that gallstone disease is the most common indication for biliary intervention. To our knowledge, this is is the most comprehensive population-based study comparing outcomes of endoscopic versus non-endoscopic interventions in patients with biliary disease and a prior history of BRS. For all patients with BRS needing biliary interventions, a majority underwent endoscopic (ERCP or enteroscopy-assisted or laparscopic-assisted ERCP) guided procedure. Patients with sepsis were significantly more likely to incur failed primary endoscopic BI and were more likely to be managed with nonendoscopic BI. Although there was no difference in inpatient mortality comparing different types of biliary intervention, primary non-endoscopic interventions were associated with increased healthcare resource utilization. Failed endoscopic interventions did not result in greater inpatient mortality but did account for increased healthcare resource utilization. Our study highlights recent trends in BRS including a steady decrease in RYGBs with a concomittant increase in sleeve gastrectomies; which is consistent with prior studies [18] . Multiple studies have illustrated the increase in prevalence of gallstones with rapid weight loss following BRS, although to varying degrees [5, 19] . Even though the total number of patients with a history of BRS doubled during the study period, the proportion of patients undergoing simultaneous cholecystectomies at the time of BRS decreased by approximately 60 %. Another study analyzing NIS trends during BRS illustrated that the proportion of patients undergoing concomitant cholecystectomy decreased from 26.3 % in 2001 to 3.7 % in 2008 [8] . Concomitant cholecystectomy during gastric bypass surgery is no longer routine practice because operative time, postoperative hospital stay, and postoperative morbidity and mortality are higher with prophylactic cholecystectomy [20] . Several studies have indicated its use only in cases of symptomatic gallbladder disease, particularly cholelithiasis [21] .
Among patients who required biliary intervention, the majority underwent primary endoscopic intervention compared to non-endoscopic intervention. The endoscopic intervention failure rate was 12 %. However, the database does not differentiate between the 3 major types of bariatric surgeries and endoscopic biliary intervention is more difficult in patients with RYGB anatomy. Furthermore, prior studies have demonstrated that 60 % to 70 % of all BRS patients had RYGB; thus, we can project that the failure rate of endoscopic biliary intervention in patients with RYGB anatomy would be 17 % to 20 % [18] . This failure rate is comparable to prior literature. With the steady decrease in RYGBs along with an increase in sleeve gastrectomies, the success rate of endoscopic biliary interventions may rise in the future, as the latter procedure, in theory, allows for easier access to the papilla compared to the former. In long limb surgical bypass patients with suspected pancreatobiliary diseases, ERCP was successful in 63 % of patients, and specifically in 88 % when the papilla was reached [22] . Common reasons for ERCP failure include afferent limb entered but papilla not reached, cannulation failure, afferent limb angulation, and jejunojejunostomy not identified [22] . Thus, a safe and effective alternative to these modalities in RYGB patients is laparoscopic transgastric endoscopy [23, 24] . Laparoscopic-assisted ERCP has been shown to be superior than balloon enteroscopy assisted ERCP with a 100 % rate of papilla identification, cannulation rate, and therapeutic success [25] . However, this procedure should be preferred in patients with Roux + biliopancreatic limb (from ligament of Treitz to jejunojejunal anastomosis) of 150 cm or longer while those with a limb length less than 150 cm should be offered deep enteroscopy-assisted ERCP first [25] .
In this study, overall mortality with either endoscopic or non-endoscopic biliary intervention was 0.41 % and there was no difference in mortality between the 2 groups. Notably, primary non-endoscopic and failed endoscopic interventions accounted for increased healthcare resource utilization. A cohort study utilizing administrative data demonstrated that in all patients presenting with biliary emergencies, failed ERCP and open cholecystectomy were associated with increased mortality and increased healthcare resource utilization [26] . Another retrospective analysis showed that failed ERCP prolongs hospital stays and increases costs of hospitalization [27] . The sickest patients in our study (those with sepsis) required primary or secondary non-endoscopic intervention and hence contributed to increased healthcare resource utilization. Failed ERCP may be a marker for sepsis resulting from delayed biliary decompression leading to increased need for hospital-based interventions. This association was demonstrated in this study where patients with sepsis were managed with non-endoscopic ▶ Original article interventions and more likely to incur failed ERCP. However, difficulties in timing an endoscopic intervention appropriately may explain why patients with sepsis were more often managed with non-endoscopic interventins. A statistically significant mortality difference may have not been seen due to the relatively low death rate and improvements in the management of sepsis [28, 29] . Early biliary intervention in patients with a history of BRS is critical when clinically indicated as patients who underwent biliary intervention within 1 day of hospitalization accounted for significantly lower health care resource utilization. The literature on the timing of endoscopic intervention after hospital admission in patients with BRS remains limited; however, early ERCP has been described in the non-bariatric population. A prospective multicenter study analyzing early ERCP (within 72 hours) versus conservative treatment for acute non-obstructive biliary pancreatitis found that early ERCP was not beneficial in these patients [30] . Other systematic reviews have also found that early ERCP does not effect mortality and complications in patients with acute gallstone pancreatitis compared to conser-▶ a) The cell's value is not displayed. As per data agreements with AHRQ, researchers cannot report any statistics where the number of observations in any given cell of analyzed data is ≤ 10. ERCP, endoscopy retrograde cholangiopancreatography vative treatment [31, 32] . However, in patients with co-exisiting cholangitis and biliary obstruction, early ERCP significantly reduced mortality and complications [31] . Given changing trends in prevalence of different types of BRS during the study period, we performed a univariate and multivariate sensitivity analysis of the study time period. Specifically, we dichotomized the study period into 2007 -2008 and 2009 -2011. Prior studies have demonstrated that gallstonerelated problems are typically seen within 1 to 2 years of bariatric surgery [33] . In one study, the mean follow-up time to cholecystectomy for symptomatic gallstone disease after BRS was 21.5 months [33] . Accordingly, we dichotomized the years into these 2 categories as our trend analysis demonstrated that the decrease in RYGB and increase in sleeve gastrectomies was after 2008. Endoscopic biliary intervention was significantly more frequent in the later time period As with all administrative databases, coding errors represent a potential limitation of the present study. In the absence of a national bariatric surgery registry, NIS represents a great data source for different types of BRS given its sophisticated sampling design and large number of observations. However, the code for prior-BRS (v45.86) is a v-code, which unfortunately does not detail the various types of bariatric surgeries. However, based on prior studies, we can project that 60 % to 70 % of all BRS patients had RYGB anatomy [18] . Moreover, the ICD-9 code for BRS has been utilized in other studies in the literature [12, 34] . In addition to the potential for miscoding, some unique features of the NIS database should be recognized. First, this study was unable to differentiate between endoscopic and laparoscopic-guided ERCP due to a lack of specificity in the ICD-9 codes. Second, the presence of an ICD-9 code for gallstones only proves an association but doesn't convey causality. Third, this database is unable to differentiate distinctive patients, and therefore patients with recurrent biliary interventions could be represented multiple times. The influence of this on the current results is uncertain but expected to be of small magnitude con-▶ (28, 564, 49, 649) sidering the statistically large sample size. Lastly, the NIS database cannot account for unobserved characteristics that may influence an intervention, complication, or outcome, so inferring "causality" from observed associations is not valid.
Conclusion
In conclusion, rates of obesity and prevalence of BRS for morbidly obese patients are increasing. In the vast majority of patients with BRS, concurrent prophylactic cholecystectomy is not performed. As a result, the most common indication for biliary intervention in this population is gallbladder-related disease. While primary endoscopic biliary intervention is more common, primary non-endoscopic intervention may be used more often for sepsis. Future research on improving success rates of endoscopic biliary intervention is prudent to reduce healthcare resource utilization. a) The cell's value is not displayed. As per data agreements with AHRQ, researchers cannot report any statistics where the number of observations in any given cell of analyzed data is ≤ 10.
